D&O Ongoing Disclosure Notice – Bevan John Walsh

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Third Age Health Services Limited
Date this disclosure made:
11-Jul-22
Date of last disclosure:
1-Mar-22
Director or senior manager giving disclosure
Full name(s):
Bevan John Walsh
Name of listed issuer:
Third Age Health Services Limited
Name of related body corporate (if applicable):
Not applicable
Position held in listed issuer:
Director
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary shares
Nature of the affected relevant interest(s):
Registered holder and beneficial
interest
For that relevant interest-
Number held in class before acquisition or disposal:
4,329,617
Number held in class after acquisition or disposal:
4,321,731
Current registered holder(s):
Bevan John Walsh
Registered holder(s) once transfers are registered:
Unknown
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 3
Details of transactions requiring disclosure-
Date of transaction:
5-Jul-22
Nature of transaction:
On market sale of ordinary shares
Name of any other party or parties to the transaction (if known):Unknown
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
$19,744.24
Number of financial products to which the transaction related: 7,743
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:
Yes
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
Yes. Bevan Walsh entered into a
deed in favour of Third Age Health
Services Limited which governs a
fixed trading plan for up to 120,000
ordinary shares held by him. These
disposals were completed pursuant
to the Plan.
Date of the prior written clearance (if any):
30 May 2022, being the date on
which Bevan Walsh entered into the
Plan.

Date of transaction:
7-Jul-22
Nature of transaction:
On market sale of ordinary shares
Name of any other party or parties to the transaction (if known):Unknown
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
$218.44
Number of financial products to which the transaction related: 86
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:
Yes
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
Yes. Bevan Walsh entered into a
deed in favour of Third Age Health
Services Limited which governs a
fixed trading plan for up to 120,000
ordinary shares held by him. These
disposals were completed pursuant
to the Plan.
Date of the prior written clearance (if any):
30 May 2022, being the date on
which Bevan Walsh entered into the
Plan.
Date of transaction:8-Jul-22
Nature of transaction:
On market sale of ordinary shares
Name of any other party or parties to the transaction (if known):Unknown
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
$144.78
Number of financial products to which the transaction related: 57
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:
Yes
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
Yes. Bevan Walsh entered into a
deed in favour of Third Age Health
Services Limited which governs a
fixed trading plan for up to 120,000
ordinary shares held by him. These
disposals were completed pursuant
to the Plan.
Date of the prior written clearance (if any):
30 May 2022, being the date on
which Bevan Walsh entered into the
Plan.
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:Not applicable
Nature of relevant interest:Not applicable
For that relevant interest,-
Number held in class:Not applicable
Current registered holder(s):Not applicable
For a derivative relevant interest,-
Type of derivative:Not applicable
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.

Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:11-Jul-22
Name and title of authorised person:
Nicholas Peter Summerfield, solicitor
to Bevan Walsh